Session 2: Update on the Treatment of Osteoporosis: Drug-Induced Osteoporosis, Current and New Drug Targets, and New Considerations in Patient Management.

Date: 7/29/2010 Check-In
1:15 pm - 1:30 pm
Educational Session: 1:30 pm - 4:30 pm
Joshua J. Neumiller, PharmD, CDE, CGP, FASCP Assistant Professor Department of Pharmacotherapy College of Pharmacy Washington State University, Live CME Instructor for University Learning Systems
Joshua J. Neumiller, PharmD, CDE, CGP, FASCP Assistant Professor Department of Pharmacotherapy College of Pharmacy Washington State University
  1. Outline and discuss the common culprits of drug-induced osteoporosis;
  2. Discuss recent evidence and treatment considerations involving calcium and vitamin D supplementation;
  3. Review and discuss currently available treatment for people with osteoporosis;
  4. Outline and discuss new drug targets for the treatment of osteoporosis and discuss recent issues and advancements regarding the management of patients with osteoporosis.
[an error occurred while processing this directive]